Lung CancerIchinose Y, Hara N, Ohta M, Yano T, Maeda K, Asoh H. Survival of patients with non-small cell lung cancer undergoing incomplete resection or exploratory thoracotomy with no resection. Lung Cancer 1993;8:265-74.Ichinose Y, Hara N, Ohta M, et al. Survival of patients with ...
aRuntime: 7:13 运行时间: 7:13[translate] ado you have a business 您有事务[translate] awhat you are borrowing it for 什么您借用它为[translate] aIn patients with advanced non-small-cell lung cancer (NSCLC), 在有先进的非小细胞肺癌(NSCLC的)病人,[translate]...
Tumor molecular biology is an increasingly important consideration when choosing therapy for patients with advanced non-small cell lung cancer (NSCLC). A number of potential biological markers are under active investigation in the hope that it will be possible to identify markers that assist in patien...
Summary of imaging findings from the SEER-Medicare linked database for patients with non-small cell lung cancer prior to receiving subsequent radiation therapy. Credit: Emily Sterbis, MD, Interventional Radiology Resident at the University of Colorado A study published in the January issue ofThe Jou...
Characteristics and outcome of ROS1-positive non-small cell lung cancer patients in routine clinical practice. J. Thorac. Oncol. 13, 1373–1382 (2018). Article PubMed Google Scholar Chen, Y. F. et al. Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 ...
aIn patients with advanced non-small-cell lung cancer (NSCLC), successive cycles of first-line platinum doublet chemotherapy are typically associated with cumulative toxicity and no increase in 在有高级非小细胞的肺癌的病人中 (NSCLC),第一线的白金成对的东西化疗的连续周期通常与累积毒性和没有增长相关...
This multicenter cohort study investigates whether hyperprogressive disease is observed in patients with advanced non–small cell lung cancer treated with
PD-L1 Introduction Immune checkpoint inhibitors (ICIs) have been shown to be an effective new strategy in the treatment of lung cancer, and their use has been established as the stand- ard treatment for patients with locally advanced/meta- static non-small cell lung cancer (NSCLC), whether in...
Plevritis, PhD JAMA Oncology Key Points Question What do the latest US data reveal about non–small cell lung cancer (NSCLC) epidemiology? Findings In this cross-sectional epidemiological analysis, NSCLC incidence decreased from 2010 to 2017 overall, but rose for patients with stage I disease. ...
1) Elderly patients with non small cell lung cancer 老年非小细胞性肺癌2) lung carcinoma of aged patients 老年性非小细胞肺癌 例句>> 3) Elderly non-small cell lung cancer 老年非小细胞肺癌 例句>> 4) elder advanced non-small cell lung cancer 老年晚期非小细胞肺癌 1. Objective To observe...